08May 2025
Challenges in Trials of Transcatheter Valve Therapy in HF

Challenges in Trials of Transcatheter Valve Therapy in HF

Mitral and tricuspid regurgitation significantly impact outcomes in heart failure, but current trial evidence for transcatheter therapies is limited by patient heterogeneity, evolving disease severity, procedural variability, and small sample sizes. This review explores these limitations and proposes methodological improvements to enhance evidence generation for these promising interventions in atrioventricular valve disease management.

  • #cardiology

Like

Save

Share